Hansa Biopharma AB (publ) (HNSBF) Short Interest Ratio & Short Volume $3.65 0.00 (0.00%) (As of 11/27/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Hansa Biopharma AB (publ) Short Interest DataHansa Biopharma AB (publ) (HNSBF) has a short interest of 541,000 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 425 shares to cover all short positions.Current Short Interest541,000 sharesPrevious Short Interest541,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1.97 millionShort Interest Ratio0.0 Days to CoverLast Record DateNovember 15, 2024Today's Trading Volume0 sharesAverage Trading Volume425 sharesToday's Volume Vs. Average0% Short Selling Hansa Biopharma AB (publ)? Sign up to receive the latest short interest report for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHNSBF Short Interest Over TimeHNSBF Days to Cover Over TimeHNSBF Percentage of Float Shorted Over Time Ad PacasoThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. Hansa Biopharma AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 10/31/2024541,000 shares $1.97 million -0.3%N/A5410 $3.65 10/15/2024542,400 shares $1.59 million No ChangeN/A0 $2.93 9/30/2024542,400 shares $1.59 million +0.3%N/A0 $2.93 9/15/2024541,000 shares $1.59 million -1.0%N/A0 $2.93 8/31/2024546,600 shares $1.60 million +1.7%N/A0 $2.93 Get the Latest News and Ratings for HNSBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024537,500 shares $1.57 million +10.9%N/A0 $2.93 7/31/2024484,500 shares $1.42 million -0.9%N/A1615 $2.93 7/15/2024489,000 shares $1.43 million -2.2%N/A0 $2.93 6/30/2024499,900 shares $1.46 million -6.5%N/A0 $2.93 6/15/2024534,700 shares $1.57 million -2.7%N/A0 $2.93 5/31/2024549,700 shares $1.61 million -4.8%N/A0 $2.93 5/15/2024577,600 shares $1.69 million No ChangeN/A0 $2.93 4/30/2024577,600 shares $1.69 million -2.1%N/A0 $2.93 4/15/2024590,200 shares $1.73 million +0.7%N/A0 $2.93 3/31/2024586,300 shares $1.72 million -1.8%N/A0 $2.93 3/15/2024596,900 shares $1.94 million +4.4%N/A746.1 $3.26 2/29/2024571,500 shares $1.86 million -0.2%N/A0 $3.26 2/15/2024572,600 shares $1.86 million +7.7%N/A2863 $3.26 1/15/2024451,800 shares $1.20 million -0.6%N/A4518 $2.65 12/31/2023454,600 shares $1.03 million -0.4%N/A235.2 $2.26 12/15/2023456,200 shares $1.37 million -0.2%N/A0 $3.00 11/30/2023457,000 shares $1.37 million +3.0%N/A0 $3.00 11/15/2023443,500 shares $1.33 million -2.4%N/A0 $3.00 10/31/2023454,500 shares $1.36 million -15.7%N/A0 $3.00 10/15/2023538,800 shares $1.62 million -0.2%N/A5388 $3.00 9/30/2023539,800 shares $2.12 million -0.5%N/A0 $3.93 9/15/2023542,500 shares $2.13 million No ChangeN/A5425 $3.93 8/31/2023542,500 shares $2.13 million +0.4%N/A1629 $3.93 8/15/2023540,200 shares $2.57 million +0.4%N/A0 $4.76 7/31/2023538,300 shares $2.85 million +1.6%N/A2691.5 $5.30 7/15/2023530,100 shares $2.81 million +3.2%N/A0 $5.30 6/30/2023513,600 shares $2.72 million -0.1%N/A0 $5.30 6/15/2023514,200 shares $2.72 million -0.1%N/A0 $5.30 5/31/2023514,700 shares $2.73 million -0.4%N/A0 $5.30 5/15/2023517,000 shares $2.74 million -0.4%N/A574.4 $5.30 4/30/2023519,100 shares $2.70 million +0.2%N/A0 $5.20 4/15/2023517,900 shares $2.69 million -0.3%N/A0 $5.20 3/31/2023519,200 shares $2.70 million +3.3%N/A0 $5.20 3/15/2023502,600 shares $2.61 million -11.4%N/A5026 $5.20The latest trend in real estate (Ad)These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. 2/28/2023567,000 shares $2.95 million +2.8%N/A0 $5.20 2/15/2023551,600 shares $2.87 million +16.0%N/A2758 $5.20 1/31/2023475,700 shares $3.14 million -0.9%N/A528.6 $6.60 1/15/2023480,000 shares $2.40 million +9.5%N/A1600 $5.01 12/30/2022438,400 shares $2.16 million -8.8%N/A0 $4.93 12/15/2022480,700 shares $2.37 million +2.0%N/A4807 $4.93 11/30/2022471,200 shares $2.27 million +2.7%N/A0 $4.82 11/15/2022458,700 shares $2.21 million +6.5%N/A655.3 $4.82 10/31/2022430,800 shares $2.48 million +0.5%N/A0 $5.75 10/15/2022428,500 shares $2.46 million -10.8%N/A0 $5.75 9/30/2022480,200 shares $2.76 million +7.9%N/A0 $5.75 9/15/2022445,000 shares $2.56 million +20.5%N/A4450 $5.75 8/31/2022369,400 shares $2.09 million +12.0%N/A284.2 $5.66 8/15/2022329,800 shares $1.87 million -22.2%N/A0 $5.66 7/31/2022424,000 shares $2.40 million +26.9%N/A0 $5.66 7/15/2022334,100 shares $1.89 million -18.6%N/A0 $5.66 6/30/2022410,600 shares $2.32 million -12.3%N/A0 $5.66 6/15/2022467,900 shares $2.65 million -10.6%N/A0 $5.66 5/31/2022523,400 shares $2.96 million -5.4%N/A0 $5.66 5/15/2022553,200 shares $3.13 million -0.7%N/A1383 $5.66 4/30/2022557,000 shares $3.25 million -0.2%N/A5570 $5.84 4/15/2022557,900 shares $3.96 million +0.6%N/A5579 $7.10 3/31/2022554,600 shares $5.13 million +7.9%N/A0 $9.25 3/15/2022513,900 shares $4.75 million -9.6%N/A0 $9.25 2/28/2022568,200 shares $5.26 million +7.4%N/A0 $9.25 2/15/2022528,900 shares $4.89 million +26.7%N/A5289 $9.25 1/31/2022417,400 shares $3.86 million +43.8%N/A0 $9.25 1/15/2022290,300 shares $2.69 million +180.5%N/A725.8 $9.25 12/31/2021103,500 shares $1.05 million -1.1%N/A0 $10.10 12/15/2021104,600 shares $1.06 million -10.0%N/A209.2 $10.10 11/30/2021116,200 shares $2.11 million +10.9%N/A0 $18.20 11/15/2021104,800 shares $1.91 million +0.3%N/A0 $18.20 10/29/2021104,500 shares $1.90 million -5.4%N/A0 $18.20 10/15/2021110,500 shares $2.01 million +0.1%N/A0 $18.20 9/30/2021110,400 shares $2.01 million +1.9%N/A0 $18.20 9/15/2021108,400 shares $1.97 million -27.4%N/A0 $18.20 8/31/2021149,200 shares $2.72 million -2.6%N/A0 $18.20 8/13/2021153,100 shares $2.79 million -23.6%N/A0 $18.20 7/30/2021200,400 shares $3.65 million -16.7%N/A0 $18.20 7/15/2021240,500 shares $4.38 million -9.0%N/A0 $18.20 6/30/2021264,200 shares $4.81 million +33.1%N/A1321 $18.20 6/15/2021198,500 shares $3.25 million -38.7%N/A0 $16.40 5/28/2021323,800 shares $5.31 million +3.4%N/A129.5 $16.40 5/14/2021313,200 shares $5.32 million -8.2%N/A0 $16.99 4/30/2021341,300 shares $5.80 million -13.2%N/A0 $16.99 4/15/2021393,200 shares $6.68 million +18.0%N/A0 $16.99 3/31/2021333,300 shares $5.66 million +15.9%N/A833.3 $16.99 3/15/2021287,500 shares $8.48 million -12.3%N/A0 $29.50 2/26/2021327,800 shares $9.67 million No ChangeN/A0 $29.50 2/12/2021327,800 shares $9.67 million -2.8%N/A0 $29.50The latest trend in real estate (Ad)These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.Don’t miss your chance to maximize your stake in this co-ownership revolution. 1/29/2021337,200 shares $9.95 million -25.2%N/A3372 $29.50 1/15/2021341,300 shares $10.07 million +107.4%N/A0 $29.50 12/31/2020342,900 shares $10.12 million +0.5%N/A0 $29.50 12/15/2020341,300 shares $10.07 million +107.4%N/A0 $29.50 11/30/2020164,600 shares $4.86 million +207.7%N/A0 $29.50 11/15/202053,500 shares $1.58 million +25.9%N/A535 $29.50 10/30/202042,500 shares $1.19 million -12.9%N/A0 $28.03 10/15/202048,800 shares $1.37 million +0.4%N/A25.7 $28.03 9/30/202048,600 shares $1.32 million -0.2%N/A486 $27.14 9/15/202048,700 shares $1.32 million +0.2%N/A0 $27.14 8/31/202048,600 shares $1.32 million +0.2%N/A0 $27.14 8/14/202048,500 shares $1.39 million -24.8%N/A0 $28.65 7/31/202064,500 shares $1.85 million -53.5%N/A13.7 $28.65 7/15/2020138,700 shares $3.70 million -25.3%N/A693.5 $26.70 6/30/2020185,600 shares $4.96 million -21.3%N/A1856 $26.70 6/15/2020235,700 shares $4.24 million -17.8%N/A0 $17.97 5/29/2020286,600 shares $3.81 million -22.9%N/A0 $13.30 5/15/2020371,900 shares $4.95 million -16.8%N/A0 $13.30 4/30/2020446,800 shares $3.73 million +3.4%N/A893.6 $8.34 4/15/2020432,300 shares $0.00 -6.9%N/A0 $0.00 3/31/2020464,400 shares $3.87 million +26.5%N/A0 $8.34 3/13/2020367,200 shares $3.06 million +140.5%N/A0 $8.34 2/28/2020152,700 shares $0.00 +60.4%N/A117.5 $0.00 2/14/202095,200 shares $793,968.00 -2.4%N/A952 $8.34 1/31/202097,500 shares $813,150.00 -3.1%N/A88.6 $8.34 1/15/2020100,600 shares $788,704.00 +3.3%N/A1006 $7.84 12/31/201997,400 shares $749,980.00 -49.4%N/A27.8 $7.70 HNSBF Short Interest - Frequently Asked Questions What is Hansa Biopharma AB (publ)'s current short interest? Short interest is the volume of Hansa Biopharma AB (publ) shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 541,000 shares of HNSBF short. Learn More on Hansa Biopharma AB (publ)'s current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Hansa Biopharma AB (publ) stock? Short selling HNSBF is an investing strategy that aims to generate trading profit from Hansa Biopharma AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hansa Biopharma AB (publ)? A short squeeze for Hansa Biopharma AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HNSBF, which in turn drives the price of the stock up even further. How often is Hansa Biopharma AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HNSBF, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies 180 Life Sciences Short Interest Data 3SBio Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Anew Medical Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HNSBF) was last updated on 11/28/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredFormer Zillow execs’ new venture targets $1.3T marketSpencer Rascoff co-founded Zillow. Austin Allison sold his company to Zillow for $125M. Now they’ve joined for...Pacaso | SponsoredTrump’s “Magic Pattern” targets stock market boomAccording to millionaire-trader Jeff Clark, President Trump's bold agenda is poised to unleash a historic trad...InvestorPlace | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hansa Biopharma AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Hansa Biopharma AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
